Bleichroeder Acquisition Corp (NASDAQ:BACQ) shares are trending higher Thursday following commentary from Citron Research highlighting the SPAC’s risk-reward profile.

BACQ shares are at critical resistance. Get the complete analysis here.

What To Know: Citron Research stated on X that BACQ represents “the most compelling risk/reward stock in the market today,” suggesting the stock could triple without hesitation.

The research firm emphasized that while policymakers debate funding for quantum computing companies that won’t deliver useful returns for years, the real national security opportunity is in Bleichroeder merger partner Merlin Labs, which trades at an approximately $800 million pre-money valuation and has existing Pentagon contracts.

“If the government is serious about strategic technology investments, this is what they should be backing,” Citron said in the post.

Citron contrasted Merlin’s valuation with quantum computing stocks, noting ...